Navigation Links
QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
Date:4/20/2009

hine or oxycodone every 6 hours for 48 hours. The study's primary clinical endpoint was changes in the pain intensity scores from baseline for MoxDuo(TM) IR versus component doses of morphine and oxycodone alone. Secondary endpoints included: (1) pain relief and global assessment of effect; and (2) safety as measured by the incidence and intensity of opioid-related adverse events.

In terms of reduced pain intensity scores and other related measures, the analgesic effects of 12mg/8mg MoxDuo(TM) IR were 80-100% greater than the components, morphine or oxycodone. The 6mg/4mg MoxDuo(TM) IR dose also showed similar improvements when compared to its individual components.

Significantly, the frequency of moderate to severe adverse events (including nausea, vomiting, constipation, dizziness, etc.) was 25% to 75% lower among patients on MoxDuo(TM) IR compared to those receiving equi-analgesic doses of morphine or oxycodone alone. Furthermore, patients receiving morphine or oxycodone alone were two to four times more likely to prematurely discontinue dosing than those on MoxDuo(TM) IR.

"These data indicate that MoxDuo(TM) IR has the potential to provide superior pain relief with a lower frequency and severity of side effects when compared to either morphine or oxycodone," said Holaday. "The improved tolerability profile should enable pain practitioners to prescribe higher doses of MoxDuo(TM) IR to achieve better pain relief with fewer side effects than morphine or oxycodone alone."

Additional studies evaluating MoxDuo(TM) IR versus Percocet(R) in patients with joint replacement surgery are underway, with results expected in Q3 of 2009.

Forward Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties. The forward-looking statements contained herein represent the judgment of QRxPharma as of the date of this release. These
'/>"/>

SOURCE QRxPharma Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
2. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
3. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
4. Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs
5. MicroPhage Successfully Completes Beta Trial for Rapid MRSA Test
6. Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens
7. Hope for Progeria - Successfully Validated on Mice, a Treatment Could Soon be Tested on Children
8. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
9. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
10. NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis
11. New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... 2014 CTI BioPharma Corp. (CTI) (NASDAQ and ... third quarter 2014 financial results on Wednesday, October 29, ... Following the announcement, members of the management team will ... and provide a general corporate update at 4:30 p.m. ... be obtained as follows: Wednesday, October 29 ...
(Date:10/17/2014)... Oct. 17, 2014  Training market researchers to ... success factor in today,s highly competitive global marketplace. ... organizations that effectively and efficiently produce high performing ... area. Effective training programs can ... recognition from internal clients by developing analysts who ...
(Date:10/17/2014)... DUBLIN , Oct. 17, 2014 ... of the "Research and Development Prospect of ... offering. Based on the 2013 ... Chinese government policies about dialysis industry and the ... in-depth research about dialysis industry segmentations. Moreover, it ...
Breaking Medicine Technology:CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2Research and Development Prospect of China Dialysis Market, 2014-2018 2Research and Development Prospect of China Dialysis Market, 2014-2018 3
... /PRNewswire-Asia/ -- Global Pharm Holdings Group, Inc. ... a China-based, growing vertically integrated pharmaceutical company ... Medicine ("TCM") herbs cultivation and processing business ... and Shandong provinces, today announced that it ...
... Oct. 26, 2011 AtheroNova Inc. (OTCBB: AHRO), a ... compounds to regress atherosclerotic plaque, today announced that it ... the U.S. Food and Drug Administration (FDA). During the ... of AHRO-001, AtheroNova,s lead patent-pending compound for the prevention ...
Cached Medicine Technology:Global Pharm Announces the Closing of US$15 Million Redeemable Convertible Bonds Financing 2Global Pharm Announces the Closing of US$15 Million Redeemable Convertible Bonds Financing 3AtheroNova Completes Successful Pre-IND Meeting with FDA on AHRO-001 2AtheroNova Completes Successful Pre-IND Meeting with FDA on AHRO-001 3
(Date:10/19/2014)... Recently, BambooIndustry.com, one of the most popular suppliers of ... bamboo deckings . Moreover, the company has launched a ... available at deeply discounted rates. , As is ... the significance of online business nowadays. Thus, BambooIndustry.com pays ... workers are striving to deliver both value and efficiency ...
(Date:10/19/2014)... 2014 This report provides comprehensive ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ... features on late-stage and discontinued projects. , Partial ...
(Date:10/19/2014)... 20, 2014 Recently, Top10BestSEOHosting.com has ... that JustHost, GoDaddy and HostMonster are the best ... (Virtual Private Server) is the method of partitioning ... of which has the appearance and capabilities of ... why the site pays close attention to VPS ...
(Date:10/19/2014)... SweetDressy.com, a professional company of women’s dresses and ... evening dresses . All the company’s old and ... discount is up to 66 percent off. , ... fashion field. Its dress specialists are striving to make ... of the world. All the company’s items are unique, ...
(Date:10/19/2014)... Stephen T. Greenberg, M.D., with offices in Woodbury, Southampton and ... as one of Long Island’s best cosmetic surgeons. In ... the best provider for Botox injections. Glisten, his Skin & ... best Laser Treatment center on Long Island.* , The voting ... the contest once per day, per IP address. , Stephen ...
Breaking Medicine News(10 mins):Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2
... for Pyratine-6(TM) and Pyratine XR(TM)NAPA, Calif., March 31 ... company engaged in the development of technologies that target ... fourth quarter and year ended December 31, 2008. Revenue ... compared with $26,471,000 reported in 2007. Revenues for ...
... DST Systems, Inc. (NYSE: DST ) has ... Systems, Inc. ("Argus"). Argus is now a wholly-owned subsidiary of ... may include forward-looking statements respecting DST and its businesses. Such ... today, and actual actions or results could differ. There could ...
... MSC Care Management, the industry,s ... post-discharge and post-injury workers, compensation claimants nationwide, announced ... Transportation, a national company also focused on the ... position in the market, providing specialized workers, compensation ...
... researchers and private sector biotech scientists will collaborate ... project to discover blood markers that could identify people ... been launched by the Framingham Heart Study. , Researchers ... to Biomarker Research in Cardiovascular Disease, will analyze about ...
... rates to those with the worst marks , , TUESDAY, March ... patients trying to figure out which hospital will provide the ... hospital safety rating conducted by the Leapfrog Group, a nonprofit ... on the safety survey had about the same rate of ...
... Minneapolis-based Courage Center, a nonprofit rehabilitation and resource center, ... , The 2009 Jay ... Center to people with disabilities who have achieved outstanding vocational ... this employment award and receive a $2,000 cash award. , ...
Cached Medicine News:Health News:Senetek PLC Reports 2008 Financial Results 2Health News:Senetek PLC Reports 2008 Financial Results 3Health News:MSC Acquires Optimal Translation & Transportation 2Health News:Effort Could Lead to Blood Tests for Heart Problems 2Health News:Study Casts Doubt on Influential Hospital Safety Survey 2Health News:Study Casts Doubt on Influential Hospital Safety Survey 3Health News:Courage Center Now Accepting Nominations for Jay and Rose Phillips Awards and Phillips Caregiver Award 2
A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates....
BD Visitec IOL Manipulator (Fenzl), blunt tip angled 45, 12.0 mm from end, fits 0.20 mm diameter holes and larger (3/bx, 1 bx/ca). For positioning intraocular lenses. Sure grip handles hand ridge ind...
... Visitec IOL Manipulator (Jaffe-Maltzman), blunt ... from end, fits 0.20 mm ... positioning intraocular lenses, (3/bx, 1 ... lenses. Sure grip handles hand ...
Sinskey lens manipulator, straight. Also available in titanium....
Medicine Products: